Rainbow Childrens Medicare Ltd (RAINBOW)
₹1,218.70
Mkt cap
₹12,378 Cr
P/E ratio
42.20
P/B
7.52
Div yield
0.29%
ROE
15.90%
ROCE
17.40%
EPS (TTM)
₹28.88
Book value
₹162
52W range
1,084–1,610
Sector
Healthcare
Price history
Previous close
Rainbow Children's Medicare Limited operates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India. The company offers a wide range of services such as newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care, obstetrics, and gynecology. [1] It is country’s largest pediatric hospital chain with 16 hospitals spread across 6 cities. [2]
NSE RAINBOWBSE 543524
Health check
Constructive
ValuationFair
ProfitabilityStrong
GrowthHigh
TechnicalsNeutral
52-week range
−24.30% from high₹1,219
₹1,084+12.43% from low₹1,610
Current
₹1,218.70
Prev close
₹1,196.80
Day
+1.83%
Price performance
1D
+2.27%
1W
+4.65%
1M
−10.51%
3M
−19.51%
6M
−3.18%
1Y
−10.04%
YTD
−7.60%
Financials
Revenue, profit & margin
P/E ratio
42.2×
RAINBOW is 5% below the sector median of 44.4×
RAINBOW42.2×
Sector median44.4×
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 333 | 336 | 341 | 330 | 417 | 398 | 370 | 353 | 445 | 445 | 460 | 470 | 548 | |
| Expenses | 215 | 218 | 236 | 236 | 270 | 264 | 255 | 249 | 296 | 298 | 315 | 335 | 378 | |
| Operating Profit | 118 | 118 | 106 | 94 | 147 | 134 | 115 | 104 | 149 | 147 | 145 | 135 | 170 | |
| OPM % | 35% | 35% | 31% | 28% | 35% | 34% | 31% | 29% | 33% | 33% | 31% | 29% | 31% | |
| Other Income | 8 | 9 | 13 | 12 | 11 | 13 | 15 | 20 | 8 | 11 | 4 | 13 | 8 | |
| Interest | 13 | 14 | 17 | 18 | 18 | 18 | 18 | 18 | 19 | 20 | 20 | 21 | 22 | |
| Depreciation | 27 | 28 | 32 | 34 | 35 | 35 | 34 | 34 | 36 | 40 | 41 | 42 | 45 | |
| Profit before tax | 85 | 85 | 69 | 53 | 105 | 94 | 77 | 71 | 102 | 98 | 87 | 84 | 112 | |
| Tax % | 26% | 26% | 26% | 26% | 25% | 27% | 27% | 25% | 26% | 24% | 10% | 26% | 25% | |
| Net Profit | 63 | 63 | 51 | 40 | 79 | 69 | 57 | 54 | 76 | 74 | 78 | 63 | 84 | |
| EPS in Rs | 6.20 | 6.12 | 5.02 | 3.89 | 7.77 | 6.76 | 5.55 | 5.27 | 7.41 | 7.14 | 7.59 | 5.96 | 8.08 | |
| Raw PDF |
Earnings
Results dates & reactionsNext results
31 Oct '26
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move −0.29% · closed higher next day 7 of last 17
| Q2FY24 | Q3FY24 | Q4FY24 | Q1FY25 | Q2FY25 | Q3FY25 | Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26† | Q1FY27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Broadcast | 31 Oct '23 | 25 Jan '24 | 20 May '24◦ | 13 Aug '24◦ | 28 Oct '24◦ | 10 Feb '25 | 24 May '25◦ | 26 Jul '25◦ | 13 Nov '25◦ | 28 Jan '26◦ | 23 May '26◦ | 30 Jul '26◦ |
| Earnings day | −6.51% | −0.52% | −4.74% | +1.59% | −2.04% | −1.02% | +0.38% | −1.00% | −1.05% | −0.30% | −0.37% | +0.32% |
| +1 day | −7.07% | +1.32% | −9.66% | −0.47% | −1.17% | −5.33% | +3.57% | −2.01% | −3.50% | −4.22% | +0.77% | +1.64% |
| +5 days | −11.25% | −3.38% | −9.01% | +0.83% | +4.81% | −6.33% | +1.62% | −3.46% | −1.90% | −5.04% | −1.00% | +2.37% |
| +15 days | −0.52% | +2.23% | −6.93% | +6.54% | +5.82% | −7.02% | +7.25% | +0.75% | −0.35% | +1.11% | +5.00% | −5.75% |
| +30 days | −1.75% | −7.33% | −7.04% | +17.35% | +8.63% | −3.83% | +16.33% | −4.34% | −1.90% | −4.67% | +5.62% | −4.98% |
| Filing | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL |
Corporate actions
Last 6 months| Kind | Value | Ex-date | Record |
|---|---|---|---|
| dividend Dividend - Rs 3.50 Per Share | 3.50 | 21 Jul '26 | 21 Jul '26 |
Shareholding
as of Sep 202649.83%Promoter
Promoters49.83%0.01
FIIs14.66%1.37
DIIs23.28%0.72
Public11.84%0.45
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | ₹8,448.00 | 57.74 | 1,21,469 | 0.24% | 610 | +34.17% | 7,044 | +20.56% | 17.45% |
| Manipal Health | ₹669.15 | 99.41 | 88,018 | 0.00% | 243 | −7.86% | 3,091 | +38.12% | 12.10% |
| Max Healthcare | ₹860.00 | 58.93 | 83,705 | 0.23% | 414 | −15.54% | 2,569 | +20.31% | 14.71% |
| Aster DM Quality | ₹681.15 | 164.50 | 59,374 | 0.44% | 29 | −46.12% | 1,311 | +21.60% | 11.57% |
| Fortis Health. | ₹768.15 | 54.36 | 57,992 | 0.13% | 273 | +3.39% | 2,545 | +17.46% | 13.45% |
| Narayana Hrudaya | ₹1,720.20 | 38.85 | 35,154 | 0.26% | 301 | +16.61% | 2,844 | +73.01% | 15.50% |
| Global Health | ₹1,270.30 | 59.66 | 34,156 | 0.04% | 157 | −0.18% | 1,304 | +26.50% | 17.37% |
| Rainbow Child. | ₹1,218.70 | 42.20 | 12,378 | 0.29% | 84 | +9.09% | 548 | +23.21% | 17.35% |
| Median: 31 Co. | ₹509.20 | 44.38 | 6,363 | 0.00% | 30 | +17.80% | 403 | +22.28% | 14.62% |
Filings
Annual reports5
Concall transcripts45
PPTOct 2026TranscriptAug 2026PPTAug 2026RECAug 2026TranscriptJun 2026PPTJun 2026TranscriptFeb 2026PPTFeb 2026RECFeb 2026TranscriptNov 2025PPTNov 2025RECNov 2025TranscriptAug 2025PPTAug 2025RECAug 2025TranscriptMay 2025PPTMay 2025TranscriptFeb 2025PPTFeb 2025TranscriptNov 2024PPTNov 2024TranscriptAug 2024PPTAug 2024RECAug 2024
Credit ratings6
Announcements5
Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised) 31 Oct - Q2 FY27 results: revenue up 23%, Nellore and Guntur hospitals started operations, new Group CFO appointed.Announcement under Regulation 30 (LODR)-Press Release / Media Release 31 Oct - Rainbow Childrens Medicare reported Q2 FY27 revenue of ₹5,480 Mn and PAT of ₹839 Mn; H1 FY27 results also released.Announcement under Regulation 30 (LODR)-Investor Presentation 31 Oct - Investor Presentation on Unaudited Standalone & Consolidated Financial Results for the Quarter and Half Year ended September 30, 2026.Unaudited Standalone & Consolidated Financial Results For Quarter And Half Year Ended September 30, 2026 31 OctBoard Meeting Outcome for Unaudited Standalone & Consolidated Financial Results For Quarter And Half Year Ended September 30, 2026 31 Oct - Board approved Q2/H1 FY27 results on Oct 31; consolidated revenue Rs 10,180.08 million, PAT Rs 818.93 million.